Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0000912057-01-519050
Filing Date
2001-06-08
Accepted
2001-06-08 00:00:00
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4/A a2051179zs-4a.txt S-4/A 746432
2 EXHIBIT 5.1 a2051179zex-5_1.txt EX-5.1 5839
3 EXHIBIT 8.1 a2051179zex-8_1.txt EX-8.1 7558
4 EXHIBIT 8.2 a2051179zex-8_2.txt EX-8.2 6874
5 EX-23.3 a2050194zex-23_3.txt EX-23.3 691
6 EXHIBIT 23.4 a2050194zex-23_4.txt EX-23.4 875
7 EXHIBIT 23.6 a2050194zex-23_6.txt EX-23.6 2389
8 EXHIBIT 23.7 a2050194zex-23_7.txt EX-23.7 666
9 EXHIBIT 23.8 a2050194zex-23_8.txt EX-23.8 726
10 EXHIBIT 99.3 a2050194zex-99_3.txt EX-99.3 2814
11 EXHIBIT 99.4 a2050194zex-99_4.txt EX-99.4 3589
  Complete submission text file 0000912057-01-519050.txt   780949
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-61480 | Film No.: 1656404
SIC: 2834 Pharmaceutical Preparations